Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shigeki Ito

Showing results (1-10 of 142) with videos related to

Pageof 15
Sort By:
Cancers|January 26, 2020
Proteasome Inhibitors for the Treatment of Multiple MyelomaShigeki Ito
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|June 3, 2026
[Recent topics in smoldering multiple myeloma: early intervention or active monitoring?]Shigeki Ito
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|October 14, 2015
[Novel agents in multiple myeloma treatment]Shigeki Ito
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|October 29, 2023
[Optimization of treatment strategy for relapsed or refractory multiple myeloma]Shigeki Ito
Nihon Rinsho. Japanese Journal of Clinical Medicine|January 29, 2015
[Consolidation and maintenance therapy after autologous hematopoietic stem cell transplantation]Shigeki Ito, Maki Asahi
Cancers|April 30, 2021
Role and Therapeutic Targeting of SDF-1α/CXCR4 Axis in Multiple MyelomaShigeki Ito, Tsuyoshi Sato, Takahiro Maeta
Anticancer Research|April 25, 2023
Dimethyl Fumarate Suppresses the Proliferation of HTLV-1-infected T Cells by Inhibiting CBM Complex-triggered NF-B SignalingTsuyoshi Sato, Takahiro Maeta, Shigeki Ito
Leukemia Research|November 9, 2015
YM155 suppresses cell proliferation and induces cell death in human adult T-cell leukemia/lymphoma cellsRyousei Sasaki, Shigeki Ito, Maki Asahi, et al.
Journal of Clinical Ultrasound : JCU|April 12, 2002
Sonographic measurement of the volume of the left lateral segment of the liverTsuyoshi Hatsuno, Tetsuya Kaneko, Shigeki Ito, et al.
Case Reports in Hematology|April 23, 2013
Successful use of cyclophosphamide as an add-on therapy for multiple myeloma patients with acquired resistance to bortezomib or lenalidomideShigeki Ito, Tatsuo Oyake, Kazunori Murai, et al.
Pageof 15

Showing results (1-10 of 142) with videos related to

Sort By:
Pageof 15
Cancers|January 26, 2020
Proteasome Inhibitors for the Treatment of Multiple MyelomaShigeki Ito
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|June 3, 2026
[Recent topics in smoldering multiple myeloma: early intervention or active monitoring?]Shigeki Ito
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|October 14, 2015
[Novel agents in multiple myeloma treatment]Shigeki Ito
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|October 29, 2023
[Optimization of treatment strategy for relapsed or refractory multiple myeloma]Shigeki Ito
Nihon Rinsho. Japanese Journal of Clinical Medicine|January 29, 2015
[Consolidation and maintenance therapy after autologous hematopoietic stem cell transplantation]Shigeki Ito, Maki Asahi
Cancers|April 30, 2021
Role and Therapeutic Targeting of SDF-1α/CXCR4 Axis in Multiple MyelomaShigeki Ito, Tsuyoshi Sato, Takahiro Maeta
Anticancer Research|April 25, 2023
Dimethyl Fumarate Suppresses the Proliferation of HTLV-1-infected T Cells by Inhibiting CBM Complex-triggered NF-B SignalingTsuyoshi Sato, Takahiro Maeta, Shigeki Ito
Leukemia Research|November 9, 2015
YM155 suppresses cell proliferation and induces cell death in human adult T-cell leukemia/lymphoma cellsRyousei Sasaki, Shigeki Ito, Maki Asahi, et al.
Journal of Clinical Ultrasound : JCU|April 12, 2002
Sonographic measurement of the volume of the left lateral segment of the liverTsuyoshi Hatsuno, Tetsuya Kaneko, Shigeki Ito, et al.
Case Reports in Hematology|April 23, 2013
Successful use of cyclophosphamide as an add-on therapy for multiple myeloma patients with acquired resistance to bortezomib or lenalidomideShigeki Ito, Tatsuo Oyake, Kazunori Murai, et al.
Pageof 15